data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
SPY
––%
QQQ
––%
BTC/USD
––%
DIA
––%
GLD
––%
TLT
––%
Trevena
(NASDAQ:TRVN)
Trevena, Inc. - Common Stock recently split on Thursday, November 10, 2022 with a ratio of 1:25
$3.45
At close: Dec 1(Delayed 15-Minutes)
Get Real Time Here
$3.75
0.3000[8.70%]
PreMarket: 8:00AM EDT
Day Range- - -52 Wk Range2.38 - 19Open / Close- / -Float / Outstanding6.9M / 6.9M
Vol / Avg.- / 43.6KMkt Cap24MP/E-50d Avg. Price4
Div / Yield-Payout Ratio-Total Float6.9MEPS-2.25

Trevena Stock (NASDAQ:TRVN), Quotes and News Summary

Trevena Stock (NASDAQ: TRVN) stock price, news, charts, stock research, profile.

Day Range- - -52 Wk Range2.38 - 19Open / Close- / -Float / Outstanding6.9M / 6.9M
Vol / Avg.- / 43.6KMkt Cap24MP/E-50d Avg. Price4
Div / Yield-Payout Ratio-Total Float6.9MEPS-2.25
Vandana Singh - Jul 28, 2022, 9:41AM
Globe Newswire - 2 days ago
Globe Newswire - Nov 16, 2022, 8:00AM
Globe Newswire - Nov 9, 2022, 4:01PM
Globe Newswire - Nov 9, 2022, 7:02AM
Globe Newswire - Nov 9, 2022, 7:00AM
Globe Newswire - Nov 7, 2022, 7:00AM
Globe Newswire - Oct 24, 2022, 7:00AM
Globe Newswire - Sep 7, 2022, 7:00AM
Globe Newswire - Aug 11, 2022, 7:00AM
Globe Newswire - Aug 8, 2022, 7:00AM
Globe Newswire - Jul 29, 2022, 5:27PM
Globe Newswire - Jul 29, 2022, 8:00AM
Globe Newswire - Jul 28, 2022, 7:00AM
Globe Newswire - Jun 14, 2022, 7:00AM
Globe Newswire - Jun 10, 2022, 7:00AM
Globe Newswire - May 18, 2022, 4:05PM
Globe Newswire - May 11, 2022, 7:00AM
Globe Newswire - May 9, 2022, 7:00AM
Globe Newswire - Apr 20, 2022, 7:00AM
Globe Newswire - Apr 18, 2022, 7:00AM
Globe Newswire - Apr 13, 2022, 4:05PM
Globe Newswire - Mar 31, 2022, 7:02AM
Globe Newswire - Mar 31, 2022, 7:00AM
Globe Newswire - Mar 30, 2022, 7:00AM
Globe Newswire - Feb 3, 2022, 7:00AM
Globe Newswire - Jan 27, 2022, 9:00AM
Globe Newswire - Jan 3, 2022, 4:05PM
Globe Newswire - Dec 13, 2021, 7:00AM
Seeking Alpha - Nov 16, 2022, 8:09AM
Seeking Alpha - Nov 13, 2022, 1:50PM
Seeking Alpha - Nov 9, 2022, 4:17PM
TipRanks - Nov 9, 2022, 11:45AM
Seeking Alpha - Nov 9, 2022, 7:04AM
Seeking Alpha - Nov 8, 2022, 1:03PM
Seeking Alpha - Aug 12, 2022, 10:23PM
TipRanks - Aug 12, 2022, 7:01AM
TipRanks - Aug 11, 2022, 1:30PM
Seeking Alpha - Jul 29, 2022, 8:36AM
TipRanks - Jul 28, 2022, 12:15PM
Seeking Alpha - Jul 28, 2022, 9:37AM
Seeking Alpha - May 13, 2022, 3:19PM
TipRanks - May 12, 2022, 11:15AM
TipRanks - May 11, 2022, 11:05AM
Seeking Alpha - May 11, 2022, 10:59AM
TipRanks - Apr 25, 2022, 11:45AM
TipRanks - Apr 24, 2022, 4:10AM
TalkMarkets - Apr 23, 2022, 1:59PM
TipRanks - Apr 20, 2022, 12:45PM
Seeking Alpha - Apr 20, 2022, 8:05AM
TipRanks - Apr 1, 2022, 11:56AM
Seeking Alpha - Mar 31, 2022, 5:44PM
TipRanks - Mar 31, 2022, 1:35PM
Seeking Alpha - Mar 31, 2022, 11:12AM
TipRanks - Jan 28, 2022, 6:59AM
Seeking Alpha - Dec 14, 2021, 2:11AM
TipRanks - Dec 13, 2021, 1:25PM
Seeking Alpha - Dec 13, 2021, 7:53AM
Sector: Health Care.Industry: Biotechnology
Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain.
Read More

Earnings

see more
Q3 2022Est.ActualSurprise
EPS-2.000-2.250 -0.2500
REV440.000K-438.000K-878.000K
Q2 2022Est.ActualSurprise
EPS-2.250
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Trevena (TRVN) stock?

A

You can purchase shares of Trevena (NASDAQ: TRVN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Trevena's (TRVN) competitors?

Q

What is the target price for Trevena (TRVN) stock?

A

The latest price target for Trevena (NASDAQ: TRVN) was reported by HC Wainwright & Co. on Thursday, May 12, 2022. The analyst firm set a price target for 3.50 expecting TRVN to rise to within 12 months (a possible 1.45% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Trevena (TRVN)?

A

The stock price for Trevena (NASDAQ: TRVN) is $3.45 last updated December 1, 2022, 9:00 PM UTC.

Q

Does Trevena (TRVN) pay a dividend?

A

There are no upcoming dividends for Trevena.

Q

When is Trevena (NASDAQ:TRVN) reporting earnings?

A

Trevena’s Q3 earnings are confirmed for Wednesday, November 9, 2022.

Q

Is Trevena (TRVN) going to split?

A

There is no upcoming split for Trevena.

Q

What sector and industry does Trevena (TRVN) operate in?

A

Trevena is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.